SI
SIG.AU Sigma Healthcare Ltd
- Market cap
- AUD 31.5B
- P/E
- 45.5x
- P/B
- 6.31x
- ROE
- 26.4%
- Dividend yield
- 1.20%
- Fundamental score
- 3.2/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Apr 2026.
Is SIG.AU undervalued?
Graham numberThe Graham number of Sigma Healthcare Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sigma Healthcare Ltd fundamental analysis
16 of 22 checks passedROE 2/2
High return on equity (26.4%), above 20%.
ROA 1/1
Return on assets (14.1%) is above the industry median (-0.3%).
Profit Consistency 1/2
Profitable for 4 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (82.7%) is above the 5-year average (71.1% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (82.7%) is above the industry median (-1.5%).
Revenue Growth 2/2
Revenue grew 43.6% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (40.4%), up to 100%.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 18.8x against interest expense, well covered.
PE vs Market 0/1
PE (45.5x) is above the market median (15.0x).
PE vs Industry 0/1
PE (45.5x) is above the industry median (27.1x).
PBV 0/1
Price to book (6.3x) is above the industry median (2.0x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 287.0, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.64, growth is cheap.
Dividend Yield 0/2
Dividend yield (1.2%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 53.4%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Sigma Healthcare Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sigma Healthcare Ltd
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS…
Full company profileSigma Healthcare Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Apr 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sigma Healthcare Ltd annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 4.37B | 4.09B | 3.98B | 3.24B | 3.40B | 3.45B | 3.66B | 3.32B | 4.89B | 10.8B | 21.3B |
| Gross Profit | 290M | 284M | 273M | 188M | 211M | 199M | 224M | 190M | 334M | 1.96B | 3.80B |
| Operating Income | 15.2M | 83.4M | -36.4M | -101M | -98.4M | -110M | -68.9M | -71.9M | 723M | 998M | 1.82B |
| EBITDA | 91.0M | 9.36M | 77.3M | 24.9M | 69.0M | 30.2M | 50.2M | 53.3M | 85.6M | 1.08B | 1.99B |
| Net Income | 53.2M | 55.1M | 36.5M | -12.3M | 43.5M | -7.24M | 1.81M | 4.51M | 530M | 709M | 1.32B |
| EPS | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.06 | 0.11 |
| Balance Sheet | |||||||||||
| Total Assets | 1.12B | 1.30B | 1.38B | 1.23B | 1.22B | 1.28B | 1.20B | 1.40B | 1.83B | 8.91B | 9.34B |
| Total Liabilities | 580M | 789M | 870M | 753M | 705M | 787M | 724M | 532M | 991M | 3.92B | 4.35B |
| Shareholders' Equity | 537M | 513M | 513M | 476M | 514M | 487M | 476M | 871M | 838M | 5.00B | 5.00B |
| Cash & Short-term Investments | 24.4M | 82.2M | 72.6M | 104M | 16.1M | 31.1M | 16.7M | 356M | 14.6M | 131M | 131M |
| Total Debt | 33.2M | 196M | 316M | 300M | 215M | 323M | 227M | 137M | 132M | 2.02B | 2.02B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 146M | 71.2M | 8.47M | 201M | 12.5M | 27.7M | 33.4M | 42.0M | 599M | 575M | 1.03B |
| Capital Expenditure | 25.2M | 62.3M | 108M | 57.1M | 77.0M | 14.2M | 29.4M | 4.72M | 7.91M | 56.7M | 133M |
| Free Cash Flow | 121M | 8.89M | -99.7M | 143M | -64.6M | 13.5M | 3.96M | 37.2M | -324M | 518M | 898M |
| Ratios | |||||||||||
| ROE | 9.9% | 10.7% | 7.1% | -2.6% | 8.5% | -1.5% | 0.4% | 0.5% | 63.2% | 14.2% | 26.4% |
| ROA | 4.8% | 4.2% | 2.6% | -1.0% | 3.6% | -0.6% | 0.2% | 0.3% | 28.9% | 8.0% | 14.1% |
| Net Profit Margin | 1.2% | 1.3% | 0.9% | -0.4% | 1.3% | -0.2% | 0.0% | 0.1% | 10.8% | 6.5% | 6.2% |
| Debt to Equity | 0.06x | 0.38x | 0.62x | 0.63x | 0.42x | 0.66x | 0.48x | 0.16x | 0.16x | 0.40x | 0.40x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Sigma Healthcare Ltd dividends
- Dividend yield
- 1.20%
- Forward dividend
- 0.04 AUD
- Payout ratio
- 53.4%
- Ex-dividend date
- Sep 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 379M | 0.03 | 53.4% |
| 2025 | AUD 17.1M | 0.00 | 3.2% |
| 2024 | AUD 9.98M | 0.00 | 221.4% |
| 2023 | AUD 15.9M | 0.00 | 880.2% |
| 2022 | AUD 19.9M | 0.00 | - |
| 2021 | AUD 1.59M | 0.00 | 3.7% |
| 2020 | AUD 30.7M | 0.00 | - |
| 2019 | AUD 41.0M | 0.00 | 112.2% |
| 2018 | AUD 55.2M | 0.01 | 100.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 5:1 on Apr 27, 2005.
Who owns Sigma Healthcare Ltd
- Insiders 55.47%
- Institutions 10.90%
- Public & others 33.63%
- Shares outstanding 11.5B
- Free float 5.10B
Sigma Healthcare Ltd company profile
- Company name
- Sigma Healthcare Ltd
- Ticker
- SIG.AU
- ISIN
- AU000000SIG5
- Exchange
- Australian Securities Exchange
- Listed since
- Oct 30, 2002
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- January
- Address
- 6 Albert Street, Preston, VIC, Australia, 3072
- Phone
- 61 3 9215 9215
- Website
- sigmahealthcare.com.au
About Sigma Healthcare Ltd
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.
Sigma Healthcare Ltd management
7- Mr. Vikesh Ramsunder B.Com.CEO, MD & Executive Director · born 1971
- Mr. Richard Murray ASIA, B.Com., B.Comm, C.A., F.C.A., Grad.Dip.Chief Financial Officer
- Ms. Danielle Di Pilla B.Sc.Chief People Officer & Executive Director
- Mr. Mario VerrocchiCEO of Retail & Executive Director
- Mr. Gary WoodfordHead of Corporate Affairs and Investor Relations
- Ms. Kara McGowan A.C.I.S., B.Com., L.L.B.General Counsel & Chief Legal Officer and Company Secretary
- Mr. Mario TasconeDeputy CEO of Retail